🇺🇸 FDA
Company

Aclaris

Aclaris Therapeutics

ACRS pharma USA

Quick answer

Aclaris is a pharma company (ACRS) headquartered in WAYNE, PA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

A-101

Common Wart

Phase 3 · small_molecule · completed

2 trials project

A-101 Solution

Seborrheic Keratosis

Phase 3 · small_molecule · completed

3 trials project

Active

Common Wart

Phase 3 · small_molecule · completed

1 trials project

A-101

Seborrheic Keratosis

Phase 2 · small_molecule · completed

2 trials project

A-101 25%

Seborrheic Keratosis (SK)

Phase 2 · small_molecule · completed

1 trials project

A-101 Solution 40

Common Warts

Phase 2 · small_molecule · completed

1 trials project

A-101 Topical Solution

Common Wart

Phase 2 · small_molecule · completed

2 trials project

A-101 Topical Solution 40%

Dermatosis Papulosa Nigra

Phase 2 · small_molecule · completed

1 trials project

A-101 Vehicle

Seborrheic Keratosis

Phase 2 · small_molecule · completed

1 trials project

ATI 502 0.46% Topical Solution

Alopecia Areata

Phase 2 · small_molecule · terminated

1 trials project

ATI-045

Atopic Dermatitis

Phase 2 · small_molecule · active

1 trials project

ATI-1777

Atopic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

ATI-1777 2.0% w/w

Atopic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

ATI-2138

Atopic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

ATI-450

Hidradenitis Suppurativa

Phase 2 · small_molecule · completed

1 trials project

ATI-450

Rheumatoid Arthritis

Phase 2 · small_molecule · completed

1 trials project

ATI-450

Cryopyrin-Associated Periodic Syndrome

Phase 2 · small_molecule · terminated

1 trials project

ATI-450

Psoriatic Arthritis

Phase 2 · small_molecule · terminated

1 trials project

ATI-450 50 mg oral tablet BID

Rheumatoid Arthritis

Phase 2 · small_molecule · completed

1 trials project

ATI-50002

Alopecia Areata

Phase 2 · small_molecule · completed

1 trials project

ATI-50002

Androgenetic Alopecia

Phase 2 · small_molecule · completed

1 trials project

ATI-50002 high dose

Alopecia Areata

Phase 2 · small_molecule · terminated

1 trials project

ATI-50002 topical solution

Vitiligo

Phase 2 · small_molecule · completed

1 trials project

ATI-501 400mg BID (Low dose)

Alopecia

Phase 2 · small_molecule · completed

1 trials

Drugs (1)

drug

hydrogen peroxide

ESKATA

Patents (8)

patent

US 12403141

Deuterated MK2 pathway inhibitors and methods of using the same

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12370195

Oral compositions of MK2 pathway inhibitor for treatment of immune conditions

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12297203

Pyrrolopyrimidine ITK inhibitors

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12281111

Substituted pyrrolopyridine JAK inhibitors and methods of making and using the s

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11844801

Oral compositions of MK2 pathway inhibitor for treatment of immune conditions

Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11820775

Pyrrolopyrimidine ITK inhibitors

Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11739086

Substituted pyrrolopyridine JAK inhibitors and methods of making and using the s

Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10981906

Substituted pyrrolopyridine JAK inhibitors and methods of making and using the s

Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)